LON:4BB 4basebio (4BB) Share Price, News & Analysis GBX 533 -17.00 (-3.09%) As of 11:58 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock About 4basebio Stock (LON:4BB) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get 4basebio alerts:Sign Up Key Stats Today's Range 533▼ 57550-Day Range 420▼ 55052-Week Range 420▼ 1,150Volume136 shsAverage Volume1,665 shsMarket Capitalization£82.54 millionP/E RatioN/ADividend YieldN/APrice TargetGBX 1,600Consensus RatingBuy Company Overview 4basebio is a specialist life sciences group focused on supplying therapeutic synthetic DNA for gene therapies and gene-based vaccines and providing solutions for effective and safe delivery of DNA/RNA based products to patients. Our focus is the development of high quality, GMP grade synthetic DNA as well as non-viral nanoparticles which can efficiently and safely deliver fully functional genes to patients. These products and technologies are also available for customers and partners with whom we endeavor to combine our capabilities and know-how to develop gene therapy solutions for clinical development and commercialisation. Read More Receive 4BB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for 4basebio and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 4BB Stock News Headlines4basebio (LON:4BB) Insider Amy Walker Buys 1,863 SharesMay 23, 2026 | insidertrades.com4basebio CEO Increases Stake with Market Purchase of Ordinary SharesMay 22, 2026 | tipranks.comI was right about SpaceXJeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,000%. Now he says SpaceX is shaping up to be the biggest IPO of the decade - and three key milestones just confirmed it. In the past 21 days: SpaceX crossed 10,000 active satellites, Elon filed confidential IPO paperwork with the SEC, and another rocket launched 25 more satellites. Two-thirds of every satellite in orbit now belongs to one company. The public filing could drop any day.June 3 at 1:00 AM | Brownstone Research (Ad)4basebio PLCMay 22, 2026 | marketwatch.com4basebio Plc - 4basebio Signs Clinical Supply Agreement to Support Phase II Clinical TrialMay 20, 2026 | uk.finance.yahoo.comFinal Results and Notice of AGMMay 20, 2026 | markets.businessinsider.com4basebio Signs Clinical Supply Agreement to Support Phase II Clinical TrialMay 20, 2026 | finance.yahoo.com4basebio Secures Seven-Figure Clinical Supply Deal for Phase II Immunotherapy TrialMay 20, 2026 | tipranks.comSee More Headlines 4BB Stock Analysis - Frequently Asked Questions How have 4BB shares performed this year? 4basebio's stock was trading at GBX 600 at the start of the year. Since then, 4BB shares have decreased by 11.2% and is now trading at GBX 533. How were 4basebio's earnings last quarter? 4basebio PLC (LON:4BB) announced its quarterly earnings results on Wednesday, May, 20th. The company reported ($1.09) EPS for the quarter. The company earned $1.69 million during the quarter. How do I buy shares of 4basebio? Shares of 4BB stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of 4basebio own? Based on aggregate information from My MarketBeat watchlists, some other companies that 4basebio investors own include B&M European Value Retail (BME), Coats Group (COA), 4D pharma (DDDD), genedrive (GDR), Greencore Group (GNC), IQE (IQE) and Omega Diagnostics Group (ODX). Company Calendar Last Earnings5/20/2026Today6/03/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:4BB CIKN/A Webwww.4basebio.com Phone44 1223 967 943FaxN/AEmployees101Year FoundedN/APrice Target and Rating Average Price Target for 4basebioGBX 1,600 High Price TargetGBX 1,600 Low Price TargetGBX 1,600 Potential Upside/Downside+200.2%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Trailing Twelve Months)GBX (99) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-£9.84 million Net MarginsN/A Pretax MarginN/A Return on Equity-231.29% Return on Assets-54.30% Debt Debt-to-Equity Ratio201.47 Current Ratio2.73 Quick Ratio3.52 Sales & Book Value Annual Sales£1.78 million Price / Sales46.39 Cash FlowGBX 33.15 per share Price / Cash Flow16.08 Book ValueGBX (41) per share Price / Book-13.00Miscellaneous Outstanding Shares15,485,000Free FloatN/AMarket Cap£82.54 million OptionableNot Optionable Beta1.09 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.Get This Free Report This page (LON:4BB) was last updated on 6/3/2026 by MarketBeat.com Staff. From Our PartnersYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredJune 12: $100 Turns Into $100,000?The SpaceX IPO is scheduled for June 12, and former tech executive Jeff Brown - who identified Bitcoin, Tesla,...Brownstone Research | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX just filed. The clock is ticking.Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...The Oxford Club | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredElon’s AI supercomputer just went live. Here’s my #1 stock.Is Elon about to trigger another 315X opportunity? Elon gave Tesla investors the chance to make more than 3...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 4basebio PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share 4basebio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
